{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T02:20:48Z","timestamp":1749349248744},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,24]]},"DOI":"10.7759\/cureus.9988","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T14:25:12Z","timestamp":1598279112000},"source":"Crossref","is-referenced-by-count":5,"title":["Stereotactic Body Radiation Therapy for Recurrent, Isolated Hepatocellular Carcinoma Lymph Node Metastasis With or Without Prior Liver Transplantation"],"prefix":"10.7759","author":[{"given":"Tyler","family":"Walburn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul H","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna K","family":"Sanoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina A","family":"McGinty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Tepper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095889","article-title":"Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis","volume":"9","author":"Xia F","year":"2014","unstructured":"Xia F, Wu L, Lau WY, Li G, Huan H, Qian C, Ma K, Bie P\r\n. Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis. PLoS One. 2014, 9:95889. 10.1371\/journal.pone.0095889","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.11395","article-title":"Surgical resection for lymph node metastasis after liver transplantation for hepatocellular carcinoma","volume":"37","author":"Ikegami T","year":"2017","unstructured":"Ikegami T, Yoshizumi T, Kawasaki J, et al.. Surgical resection for lymph node metastasis after liver transplantation for hepatocellular carcinoma. Anticancer Res. 2017, 37:891-895. 10.21873\/anticanres.11395","journal-title":"Anticancer Res"},{"key":"ref3","unstructured":"National Comprehensive Cancer Network, hepatobiliary cancers. (2019). Accessed. January 14, 2020: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/hepatobiliary.pdf."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/cld.802","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero JA","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, et al.. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018, 68:723-750. 10.1002\/cld.802","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.4925","article-title":"Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma","volume":"34","author":"Wahl DR","year":"2016","unstructured":"Wahl DR, Stenmark MH, Tao Y, et al.. Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma. J Clin Oncol. 2016, 34:452-459. 10.1200\/JCO.2015.61.4925","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.05.066","article-title":"Comparison of stereotactic body radiation therapy and transarterial chemoembolization for unresectable medium-sized hepatocellular carcinoma","volume":"105","author":"Shen PC","year":"2019","unstructured":"Shen PC, Chang WC, Lo CH, et al.. Comparison of stereotactic body radiation therapy and transarterial chemoembolization for unresectable medium-sized hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2019, 105:307-318. 10.1016\/j.ijrobp.2019.05.066","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2018.12.013","article-title":"Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma","volume":"131","author":"Kim N","year":"2019","unstructured":"Kim N, Kim HJ, Won JY, et al.. Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma. Radiother Oncol. 2019, 131:81-87. 10.1016\/j.radonc.2018.12.013","journal-title":"Radiother Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer EA","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al.. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009, 45:228-247. 10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez DR","year":"2019","unstructured":"Gomez DR, Tang C, Zhang J, et al.. Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study. J Clin Oncol. 2019, 37:1558-1565. 10.1200\/JCO.19.00201","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma DA","year":"2019","unstructured":"Palma DA, Olson R, Harrow S, et al.. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet. 2019, 393:2051-2058. 10.1016\/S0140-6736(18)32487-5","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14623","article-title":"Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study","volume":"18","author":"Jeng LB","year":"2018","unstructured":"Jeng LB, Lee SG, Soin AS, et al.. Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study. Am J Transplant. 2018, 18:1435-1446. 10.1111\/ajt.14623","journal-title":"Am J Transplant"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15551","article-title":"Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation","volume":"19","author":"Iavarone M","year":"2019","unstructured":"Iavarone M, Invernizzi F, Czauderna C, et al.. Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation. Am J Transplant. 2019, 19:3176-3184. 10.1111\/ajt.15551","journal-title":"Am J Transplant"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-012-1533-0","article-title":"Resection of pulmonary metastases from hepatocellular carcinoma following liver transplantation","volume":"36","author":"Hwang S","year":"2012","unstructured":"Hwang S, Kim YH, Kim DK, et al.. Resection of pulmonary metastases from hepatocellular carcinoma following liver transplantation. World J Surg. 2012, 36:1592-1602. 10.1007\/s00268-012-1533-0","journal-title":"World J Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20128","article-title":"Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis","volume":"10","author":"Roayaie S","year":"2004","unstructured":"Roayaie S, Schwartz JD, Sung MW, et al.. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl. 2004, 10:534-540. 10.1002\/lt.20128","journal-title":"Liver Transpl"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000001894","article-title":"Predicting mortality in patients developing recurrent hepatocellular carcinoma after liver transplantation: impact of treatment modality and recurrence characteristics","volume":"266","author":"Bodzin AS","year":"2017","unstructured":"Bodzin AS, Lunsford KE, Markovic D, Harlander-Locke MP, Busuttil RW, Agopian VG. Predicting mortality in patients developing recurrent hepatocellular carcinoma after liver transplantation: impact of treatment modality and recurrence characteristics. Ann Surg. 2017, 266:118-125. 10.1097\/SLA.0000000000001894","journal-title":"Ann Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/lt.24742","article-title":"Recurrence of hepatocellular carcinoma after liver transplantation: is there a place for resection?","volume":"23","author":"Fernandez-Sevilla E","year":"2017","unstructured":"Fernandez-Sevilla E, Allard MA, Selten J, et al.. Recurrence of hepatocellular carcinoma after liver transplantation: is there a place for resection?. Liver Transpl. 2017, 23:440-447. 10.1002\/lt.24742","journal-title":"Liver Transpl"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.03.058","article-title":"Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients","volume":"63","author":"Zeng ZC","year":"2005","unstructured":"Zeng ZC, Tang ZY, Fan J, et al.. Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients. Int J Radiat Oncol Biol Phys. 2005, 63:1067-1076. 10.1016\/j.ijrobp.2005.03.058","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi Z","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, et al.. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018, 15:11-20. 10.1038\/nrgastro.2017.109","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2017.02.001","article-title":"Normal tissue constraints for abdominal and thoracic stereotactic body radiotherapy","volume":"27","author":"Pollom EL","year":"2017","unstructured":"Pollom EL, Chin AL, Diehn M, Loo BW, Chang DT. Normal tissue constraints for abdominal and thoracic stereotactic body radiotherapy. Semin Radiat Oncol. 2017, 27:197-208. 10.1016\/j.semradonc.2017.02.001","journal-title":"Semin Radiat Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2019.07.018","article-title":"Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) guidelines for pancreatic stereotactic body radiation therapy (SBRT)","volume":"10","author":"Oar A","year":"2020","unstructured":"Oar A, Lee M, Le H, et al.. Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) guidelines for pancreatic stereotactic body radiation therapy (SBRT). Pract Radiat Oncol. 2020, 10:e136-e146. 10.1016\/j.prro.2019.07.018","journal-title":"Pract Radiat Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i45.5081","article-title":"Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: a proposed management algorithm","volume":"24","author":"Au KP","year":"2018","unstructured":"Au KP, Chok KS. Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: a proposed management algorithm. World J Gastroenterol. 2018, 24:5081-5094. 10.3748\/wjg.v24.i45.5081","journal-title":"World J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/36974-stereotactic-body-radiation-therapy-for-recurrent-isolated-hepatocellular-carcinoma-lymph-node-metastasis-with-or-without-prior-liver-transplantation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:25:20Z","timestamp":1707506720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/36974-stereotactic-body-radiation-therapy-for-recurrent-isolated-hepatocellular-carcinoma-lymph-node-metastasis-with-or-without-prior-liver-transplantation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,24]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.9988","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,24]]}}}